Health Care/Hospital

Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials

KYOTO, Japan, Oct. 7, 2024 /PRNewswire/ -- Rege Nephro Co., Ltd. ( https://www.regenephro.co.jp/ ) is excited to  announcethat the company has successfully developed a funding plan of total approximately17 million dollar (2.5 billion JPY) in new Series B funding and ...

2024-10-09 07:39 2372

Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference

GUANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US...

2024-10-09 04:30 1368

High tech specs and adapted World Cup pitch sensors awarded share of £1.5m as finalists in Longitude Prize on Dementia

* AI glasses that help people living with dementia navigate their environment and a smartwatch that learns daily routines to assist in everyday tasks are among five groundbreaking technologies announced as finalists in The Longitude Prize on Dementia * The Longitude Prize on Dementia is a £4....

2024-10-09 02:30 1910

Ubie, Inc. adds Google as an investor in its latest funding round

NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Ubie Inc. is pleased to announce that it has received investment from Google in its latest funding round. Ubie and Google investment Through this deal, the two companies agreed to help advance digita...

2024-10-08 21:00 6976

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

* Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative * The two companies will co-establish a NewCo in Spain to serve as a strategic hub inEurope, accelerating global ex...

2024-10-08 21:00 1621

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for in...

2024-10-08 20:30 3083

Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PFL-241/STX-241 is a highly selective, and potentially best-in-class fourth generation epidermal growth factor receptor ("EGFR") inhibitor One of two EGFR programs being developed with Scorpion Therapeutics CASTRES, France and BOSTON, Oct. 8, 2024 /PRNewswire/ -- Pierre Fabre Laboratories, a glo...

2024-10-08 20:00 1330

Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

* SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. * With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, including those for pneumoniae and typhoid. * The ...

2024-10-08 20:00 1450

Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test

Healgen Rapid Check® COVID-19/Flu A&B Antigen Test was supported through the Independent Test Assessment Program (ITAP), a National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. HOUSTON, Oct. 8, 2024 /PRNewswire/ -- Healgen Scientific LLC, a leading innovator...

2024-10-08 19:00 1223

Pop culture meets a sense of wellbeing: inspiring ToyTrends for Spielwarenmesse 2025

* Two new trends: 'Anime & Friends' and 'Healthy Heroes' * Perfect position: new central location at Eingang Mitte NUREMBERG, Germany, Oct. 8, 2024 /PRNewswire/ -- From 28 January to 1 February 2025, Nuremberg will again become the centre of the global toy sector. The international TrendCommi...

2024-10-08 16:07 1176

MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections

FOSTER CITY, Calif., Oct. 8, 2024 /PRNewswire/ -- MicuRx Pharmaceuticals is excited to announce the publication of groundbreaking research on MRX-5, a novel oral oxaborole prodrug, demonstrating significant potential in the treatment of pulmonary infections caused byMycobacterium abscessus (Mab),...

2024-10-08 13:38 990

Herbalife Sets GUINNESS WORLD RECORDS™ Title with 2024 Worldwide Workout

More than 4,900 fitness enthusiasts from around the world participated in a high-intensity interval training workout LOS ANGELES, Oct. 8, 2024 /PRNewswire/ -- Herbalife , a premier health and wellness company, community and platform, has made history by setting a...

2024-10-08 11:00 4333

Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC

ROCKVILLE, Md. and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that APG-2449, a FAK/ALK...

2024-10-08 10:26 1470

Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)

BEIJING and HANGZHOU, China, Oct. 7, 2024 /PRNewswire/ -- The 32nd United European Gastroenterology Week (UEG Week 2024) will take place inVienna, Austria , fromOctober 12 to 15, 2024. UEG Week is the largest gastroenterology conference inEurope and one of the leading meetings worldwide. It brings...

2024-10-08 10:00 1253

Empowering Elder Care: DKSH's Mission for "Patient Purpose Day 2024"

For the second consecutive year, DKSH Healthcare Business Unit is marking "Patient Purpose Day 2024" with a series of impactful initiatives acrossAsia dedicated to elder care. These programs, which include health screenings, educational workshops, and donation drives, aim to meet the needs of ...

2024-10-08 09:00 3325

MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy

SUZHOU, China, Oct. 7, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announced a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen will lead a global clinical study to evaluate the therapeutic poten...

2024-10-08 08:00 1355

Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2024-10-08 08:00 1649

Korean and Brazilian doctors take anti-aging thread lifting technology classes at Juan Clinic in Korea

SEOUL, South Korea, Oct. 8, 2024 /PRNewswire/ -- In early September this year, Juan Clinic hosted a live training session for around 150 Korean and Brazilian doctors, where Korean directors with extensive experience in thread lifting procedures for wrinkle reduction shared their expertise. About ...

2024-10-08 08:00 1348

Meridian Innovation Secures US$12.5 Million in Funding from Strategic Partner, Existing Investors and New Investors to Accelerate Growth

SINGAPORE, Oct. 8, 2024 /PRNewswire/ -- Meridian Innovation Pte Ltd, the pioneer developer of low cost, mass producible thermal imaging sensors, is pleased to announce it has raisedUS$12.5 million in a funding round led by new investors, strategic partners, as well as participation from existing ...

2024-10-08 08:00 2031

Australian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy

MELBOURNE, Australia, Oct. 8, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved the use of Illuccix® (kit for the preparation of68Ga-PSMA-11[1] injection) to select patients for...

2024-10-08 04:00 1628
1 ... 23242526272829 ... 847